Non-canonical autophagy drives alternative ATG8 conjugation to phosphatidylserine
Alf H Lystad,
Sven R Carlsson,
Michael I Wilson,
Andrea F Lopez-Clavijo,
Michael J Wakelam,
Posted 15 May 2020
bioRxiv DOI: 10.1101/2020.05.14.096115
Posted 15 May 2020
Autophagy is a fundamental catabolic process essential for development, homeostasis and proper immune function. During autophagy, a cascade of ATG proteins target intracellular cargoes for lysosomal degradation and recycling. This pathway utilises a unique post-translational modification, the conjugation of ATG8 proteins to phosphatidylethanolamine (PE) at autophagosomes, which modulates cargo selection and maturation. ATG8 lipidation also occurs during non-canonical autophagy, a parallel pathway involving Single Membrane ATG8 Conjugation (SMAC) to endolysosomal compartments, which plays a key role in phagocytosis and other processes. It has been widely assumed that SMAC involves the same lipidation of ATG8 to PE, but this has yet to be formally tested. Here, we show that ATG8 undergoes alternative lipidation to phosphatidylserine (PS) during non-canonical autophagy/SMAC. Using mass spectrometry, we find that activation of SMAC, by pharmacological agents or during non-canonical autophagy processes such as LC3-associated phagocytosis and Influenza A virus infection, induces the covalent conjugation of ATG8 to PS, as well as PE. This alternative lipidation event is dependent on the ATG16L1 WD40 domain, and occurs at PS enriched endolysosomal membranes. Importantly, we find that the ATG8-PS and ATG8-PE adducts are differentially delipidated by isoforms of the ATG4 family, indicating significant molecular distinctions and mechanisms between these two species. Together, these results provide an important new insight into autophagy signalling, revealing an alternative form of the hallmark ATG8-lipidation event, so widely used to define and assay autophagy. Furthermore, ATG8-PS lipidation provides a specific ″molecular signature″ for non-canonical autophagy, uncovering a novel means of detecting and monitoring this emerging pathway. ### Competing Interest Statement The authors have declared no competing interest.
- Downloaded 1,007 times
- Download rankings, all-time:
- Site-wide: 29,357
- In cell biology: 1,090
- Year to date:
- Site-wide: 101,838
- Since beginning of last month:
- Site-wide: 114,564
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!